The proposed rule amendment will update the rule text to remove the abbreviations and definitions no longer in use.

 

DEPARTMENT OF HEALTH

Board of Medicine

RULE NO.:RULE TITLE:

64B8-14.002Abbreviations and Definitions

PURPOSE AND EFFECT: The proposed rule amendment will update the rule text to remove the abbreviations and definitions no longer in use.

SUMMARY: To update the rule text.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board concluded that this rule change will not have any impact on licensees and their businesses or the businesses that employ them. The rule will not increase any fees, business costs, personnel costs, will not decrease profit opportunities, and will not require any specialized knowledge to comply. This change will not increase any direct or indirect regulatory costs. Hence, the Board determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 458.309, 458.314(4) FS.

LAW IMPLEMENTED: 458.3148 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: : Paul Vazquez, J.D., Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253, [e-mail]

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

64B8-14.002 Abbreviations and Definitions.

As used in this chapter:

(1) “AAMC” means Association of American Medical Colleges.

(2) “ACGME” means Accreditation Council for Graduate Medical Education.

(3) “AMA” means American Medical Association.

(4)  through (5) renumbered   (1) through (2)  No change. 

(6) “Clinical clerkship” means an organized supervised educational experience involving the examination and care of patients in the practice of medicine, which is an integral part of the clinical component of the medical curriculum and which takes place in a teaching hospital or an acceptable equivalent health care facility.

(7) “Dean” means a university or college administrative official acting as chief academic officer in the supervision of a school or faculty.

(8) renumbered to (3) No change.

(9) “ECFMG” means Educational Commission for Foreign Medical Graduates.

(10) “FLEX” means Federation Licensing Examination.

(11) “FMGEMS” means Foreign Medical Graduate Examination in the Medical Sciences.

(12) renumbered to (4) No change.

(13) “LCME” means Liaison Committee on Medical Education.

(14) “M.D. DEGREE” means an abbreviation for Medicine Doctor, Doctor of Medicine, an academic degree conferred by a college/university on one having satisfactorily completed a medical school curriculum established for preparation for the practice of medicine. Other degrees (example M.B.) are used as equivalent in some countries.

Rulemaking Authority 458.309, 458.314(4) FS. Law Implemented 458.314 FS. History–New 8-24-87, Formerly 21M-41.002, 61F6-41.002, 59R-14.002,    Amended                .

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Rules/Legislative Committee, Board of Medicine

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Medicine

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: April 8, 2022

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: April 28, 2022